STOCKWATCH
·
Pharmaceuticals
New Launch10 Apr 2025, 03:39 am

OneSource Specialty Pharma Secures Brazilian GMP Approval for Unit 2

AI Summary

OneSource Specialty Pharma Limited has been granted Good Manufacturing Practices (GMP) certification by ANVISA, the Brazilian Health Regulatory Agency, for its flagship Unit 2 facility. The certification follows a successful regulatory inspection from November 18, 2024 to November 22, 2024.

Key Highlights

  • OneSource Specialty Pharma Limited has received GMP certification from ANVISA for its Unit 2 facility
  • The certification is a testament to the company's commitment to quality and regulatory compliance
ONESOURCE
Pharmaceuticals
Onesource Specialty Pharma Ltd

Price Impact